Sandy Spring Bank’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $21.1M | Buy |
25,550
+4,546
| +22% | +$3.78M | 0.89% | 25 |
|
|
2024
Q4 | $16.2M | Buy |
21,004
+1,853
| +10% | +$1.53M | 0.66% | 30 |
|
|
2024
Q3 | $17M | Buy |
19,151
+1,473
| +8% | +$1.32M | 0.7% | 31 |
|
|
2024
Q2 | $16M | Buy |
17,678
+1,546
| +10% | +$1.24M | 0.71% | 29 |
|
|
2024
Q1 | $12.6M | Buy |
16,132
+296
| +2% | +$211K | 0.57% | 36 |
|
|
2023
Q4 | $9.23M | Buy |
15,836
+905
| +6% | +$528K | 0.46% | 51 |
|
|
2023
Q3 | $8.02M | Buy |
14,931
+1,908
| +15% | +$983K | 0.45% | 54 |
|
|
2023
Q2 | $6.11M | Buy |
13,023
+613
| +5% | +$257K | 0.33% | 73 |
|
|
2023
Q1 | $4.26M | Buy |
12,410
+2,718
| +28% | +$917K | 0.24% | 96 |
|
|
2022
Q4 | $3.55M | Buy |
9,692
+2,407
| +33% | +$853K | 0.21% | 113 |
|
|
2022
Q3 | $2.35M | Buy |
7,285
+1,553
| +27% | +$492K | 0.15% | 134 |
|
|
2022
Q2 | $1.86M | Sell |
5,732
-394
| -6% | -$118K | 0.11% | 158 |
|
|
2022
Q1 | $1.75M | Buy |
6,126
+1,396
| +30% | +$359K | 0.09% | 173 |
|
|
2021
Q4 | $1.31M | Sell |
4,730
-151
| -3% | -$38.3K | 0.06% | 194 |
|
|
2021
Q3 | $1.13M | Buy |
4,881
+1,250
| +34% | +$309K | 0.06% | 199 |
|
|
2021
Q2 | $834K | Sell |
3,631
-145
| -4% | -$29.1K | 0.04% | 219 |
|
|
2021
Q1 | $705K | Sell |
3,776
-88
| -2% | -$17.2K | 0.04% | 223 |
|
|
2020
Q4 | $652K | Buy |
3,864
+972
| +34% | +$145K | 0.04% | 222 |
|
|
2020
Q3 | $428K | Sell |
2,892
-21
| -0.7% | -$3.25K | 0.03% | 240 |
|
|
2020
Q2 | $478K | Buy |
2,913
+1,216
| +72% | +$187K | 0.04% | 232 |
|
|
2020
Q1 | $235K | Sell |
1,697
-162
| -9% | -$22.3K | 0.02% | 267 |
|
|
2019
Q4 | $245K | Buy |
1,859
+94
| +5% | +$10.9K | 0.02% | 281 |
|
|
2019
Q3 | $197K | Buy |
1,765
+665
| +60% | +$74K | 0.02% | 299 |
|
|
2019
Q2 | $122K | Hold |
1,100
| – | – | 0.01% | 343 |
|
|
2019
Q1 | $142K | Sell |
1,100
-165
| -13% | -$20.1K | 0.01% | 320 |
|
|
2018
Q4 | $146K | Hold |
1,265
| – | – | 0.01% | 311 |
|
|
2018
Q3 | $136K | Sell |
1,265
-257
| -17% | -$25.7K | 0.01% | 332 |
|
|
2018
Q2 | $130K | Sell |
1,522
-100
| -6% | -$8.21K | 0.01% | 344 |
|
|
2018
Q1 | $125K | Sell |
1,622
-354
| -18% | -$28.5K | 0.01% | 348 |
|
|
2017
Q4 | $167K | Sell |
1,976
-608
| -24% | -$51.7K | 0.02% | 300 |
|
|
2017
Q3 | $221K | Buy |
2,584
+47
| +2% | +$3.85K | 0.02% | 277 |
|
|
2017
Q2 | $209K | Buy |
2,537
+339
| +15% | +$27.7K | 0.02% | 290 |
|
|
2017
Q1 | $185K | Buy |
2,198
+750
| +52% | +$60.1K | 0.02% | 291 |
|
|
2016
Q4 | $107K | Sell |
1,448
-1,195
| -45% | -$89K | 0.01% | 344 |
|
|
2016
Q3 | $212K | Buy |
2,643
+1,100
| +71% | +$88K | 0.02% | 282 |
|
|
2016
Q2 | $122K | Hold |
1,543
| – | – | 0.01% | 333 |
|
|
2016
Q1 | $111K | Sell |
1,543
-236
| -13% | -$17.9K | 0.01% | 342 |
|
|
2015
Q4 | $150K | Buy |
1,779
+35
| +2% | +$2.9K | 0.02% | 300 |
|
|
2015
Q3 | $146K | Sell |
1,744
-408
| -19% | -$34.4K | 0.02% | 302 |
|
|
2015
Q2 | $179K | Buy |
2,152
+111
| +5% | +$8.46K | 0.02% | 304 |
|
|
2015
Q1 | $148K | Buy |
2,041
+13
| +0.6% | +$926 | 0.02% | 312 |
|
|
2014
Q4 | $140K | Buy |
2,028
+275
| +16% | +$18.6K | 0.02% | 296 |
|
|
2014
Q3 | $114K | Buy |
1,753
+1,000
| +133% | +$63.3K | 0.01% | 319 |
|
|
2014
Q2 | $47K | Hold |
753
| – | – | 0.01% | 424 |
|
|
2014
Q1 | $44K | Buy |
753
+500
| +198% | +$27.9K | 0.01% | 390 |
|
|
2013
Q4 | $13K | Sell |
253
-75
| -23% | -$3.76K | ﹤0.01% | 534 |
|
|
2013
Q3 | $17K | Sell |
328
-75
| -19% | -$3.93K | ﹤0.01% | 492 |
|
|
2013
Q2 | $19K | Buy |
+403
| New | +$21.9K | ﹤0.01% | 454 |
|
Other funds holding LLY
Sandy Spring Bank's LLY Position: Q1 2025 in Review
Sandy Spring Bank increased its Eli Lilly (LLY) stake by 22% in Q1 2025, buying an estimated $3.78M and bringing the position to 25,550 shares worth $21.1M. The position accounts for 0.89% of the portfolio, ranked #25.
Sandy Spring Bank first reported a position in LLY in Q2 2013 and has held it in 48 quarters since. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.
- Sandy Spring Bank held 25,550 shares of Eli Lilly worth $21.1M as of Q1 2025.
- Sandy Spring Bank bought 4,546 Eli Lilly shares in Q1 2025, an estimated $3.78M.
- Eli Lilly made up 0.89% of Sandy Spring Bank's portfolio in Q1 2025, its #25 holding.
- Sandy Spring Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 48 quarters since.
- 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.
Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.